[go: up one dir, main page]

SE0601589L - Administrering av opioider - Google Patents

Administrering av opioider

Info

Publication number
SE0601589L
SE0601589L SE0601589A SE0601589A SE0601589L SE 0601589 L SE0601589 L SE 0601589L SE 0601589 A SE0601589 A SE 0601589A SE 0601589 A SE0601589 A SE 0601589A SE 0601589 L SE0601589 L SE 0601589L
Authority
SE
Sweden
Prior art keywords
opioids
administration
Prior art date
Application number
SE0601589A
Other languages
English (en)
Inventor
Gayatri Sathyan
Nipun Davar
Linda H Pors
Gemma Casadevall
Jayne Hastedt
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Priority to SE0602280A priority Critical patent/SE0602280L/sv
Publication of SE0601589L publication Critical patent/SE0601589L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE0601589A 2005-10-31 2006-07-20 Administrering av opioider SE0601589L (sv)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE0602280A SE0602280L (sv) 2005-10-31 2006-10-30 Förfaranden för minskning av alkoholinducerad dosdumpning för orala opioiddosformer med fördröjt frisättande

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73199505P 2005-10-31 2005-10-31
US80201706P 2006-05-18 2006-05-18

Publications (1)

Publication Number Publication Date
SE0601589L true SE0601589L (sv) 2007-05-01

Family

ID=36758362

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0601589A SE0601589L (sv) 2005-10-31 2006-07-20 Administrering av opioider

Country Status (11)

Country Link
BG (1) BG1070U1 (sv)
CA (6) CA2554698A1 (sv)
CZ (1) CZ19137U1 (sv)
DK (1) DK200600189U3 (sv)
FI (1) FI7357U1 (sv)
GB (1) GB0612326D0 (sv)
IE (1) IES20060507A2 (sv)
NL (1) NL1032148C1 (sv)
NO (1) NO20063233L (sv)
SE (1) SE0601589L (sv)
SK (1) SK5202Y1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2187873B1 (en) 2007-08-13 2018-07-25 Abuse Deterrent Pharmaceutical Llc Abuse resistant drugs, method of use and method of making
US20140275150A1 (en) 2013-03-15 2014-09-18 Inspirion Delivery Technologies, Llc Abuse deterrent compositions and methods of use
US10729685B2 (en) 2014-09-15 2020-08-04 Ohemo Life Sciences Inc. Orally administrable compositions and methods of deterring abuse by intranasal administration
US10172842B2 (en) * 2015-09-11 2019-01-08 PharmaDax Inc. Sustained release oral dosage form containing dalfampridine
CN111465396B (zh) 2017-12-20 2024-07-09 普渡制药公司 防滥用硫酸吗啡剂型

Also Published As

Publication number Publication date
BG1070U1 (bg) 2008-06-30
FI7357U1 (sv) 2007-01-16
CA2554684A1 (en) 2007-04-30
SK5202Y1 (en) 2009-06-05
CA2554874A1 (en) 2007-04-30
DK200600189U3 (da) 2007-02-23
GB0612326D0 (en) 2006-08-02
CZ19137U1 (cs) 2008-12-08
CA2554701A1 (en) 2007-04-30
CA2554697A1 (en) 2007-04-30
IES20060507A2 (en) 2007-05-30
CA2554698A1 (en) 2007-04-30
NL1032148C1 (nl) 2006-11-17
CA2554693A1 (en) 2007-04-30
SK50572006U1 (en) 2009-01-07
FIU20060296U0 (sv) 2006-07-12
NO20063233L (no) 2007-05-02

Similar Documents

Publication Publication Date Title
CY2022001I1 (el) Παραγωγα του uk-2a
CY2014012I2 (el) Χορηγηση αναστολεων διπεπτιδυλοπεπτιδασης
DK1720866T3 (da) Fremgangsmåde
DK2073795T3 (da) Misbrugssikret lægemiddelformulation
DOP2007000084A (es) Derivados de dihidropirazolopirimidinona
DK1940467T3 (da) Lægemiddelsammensætning med langvarig frigivelse
DE602007003775D1 (de) Lautsprecher
DK2035369T3 (da) Terapeutiske
CR10809A (es) Derivados de heteroaril-pirrolidinil-y-piperidinil-cetona
JP2006122056A5 (ja) β-グルカンの使用
DK1957073T3 (da) Lægemiddel
FI20065757A0 (sv) Användning av beta-laktamas
NO20043305D0 (no) Preparation of lodixanol
NO20083139L (no) Anvendelse av hyllebærekstrakt
NO20055643D0 (no) Preparation of lodixanol
DE602006019800D1 (de) Paniermaschine
EP1906944A4 (en) SKI ANDRIN-B-PREPARATION
EP1833278A4 (en) Speaker
SE0601589L (sv) Administrering av opioider
BRPI0812832A2 (pt) Combinação farmacêutica de opioides e composto de prostaglandina
AT9745U3 (de) Liegendholzspalter
FR2877833B1 (fr) Correcteur de lordoses
FI20055133A0 (sv) Slaganordning
UA12944S (uk) Стіна павільйону
ITMO20040025A1 (it) Mezzi di collegamento

Legal Events

Date Code Title Description
NAV Patent application has lapsed